FDA Approves mRNA Flu Shot for Seniors | Virginia Beach News

FDA just approved a new mRNA flu vaccine for adults 50+, developed by Moderna and called mFlusiva—same tech that revolutionized COVID shots. It’s faster to produce, could be crucial if flu mutates, and shows strong protection: 27% fewer cases in 50-64s, with accelerated approval for 65+. Side effects are mild—pain, fever, fatigue—but no major safety red flags. Approval came after a brief setback when an FDA official initially blocked it, but the agency reversed course after Moderna’s push and backing from an independent advisory panel. Could hit pharmacies soon. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e89b0a08111c6093